menu
search
    menu

    HealthBank

    World's first people-owned healthdata transaction platform

    • Asset
      Fund
    • Sale Status
      Ended
    About

    HEALTHBANK: YOUR DATA, YOUR HEALTH - OWN IT!
    Health is the number one source of wellbeing and happiness - and it is the pillar we rely on to lead a fulfilled life. Day by day, we are getting better tracking our own health.

    Just as humankind has entered the digital age, our health has become digitalized too. Health records are increasingly recorded digitally, medical prescriptions are transmitted electronically and tracking one’s personals health and wellbeing has become the new normal.

    We act as a game changer in the global health data market by offering providers, users and healthcare professionals a secure and trusted environment for all health-related data - from fitness to medical data; from Electronic to Personal Health Records (PHR) and from eMedications to medical therapy plans, and many more

     

    THE PROBLEM
    Large amounts of personal health data is generated and shared freely and insecurely through apps and personal devices, which often comes without necessary protection.

     

    OUR SOLUTION: PRIVACY YOU CAN BANK ON
    healthbank has set out to change this: with its safe, secure and compliant ecosystem, healthbank is on its way to becoming the leading health data hub for the 21st century.

    healthbank only cooperates with providers who are compliant to its regulatory framework, which is based on the European GDPR and acts in accordance with the highest legal and ethical standards in data protection eMedications to medical therapy plans, and many more.

    Industry
    Social Networks
    Team

    • Reto Schegg
      CEO
    • Uwe Diegel
      Head of Product Management
    • Rolf Eleveld
      Head of IT and Software Development
    • Jacques Fellay
      Chief Medical Officer and Founding Partner
    • Karsten Stampa
      COO/CFO
    • Daniela Gunz
      Director of Research Partnerships

    OPERATIONS TEAM

    • Carolina Breitenmoser
      Finance and Office Assistent
    • Pauline Geniets
      Marketing Manager Investor Relations
    • Hans Hess
      Director Project Development and Implementation
    • Mel Padden
      Full Stack Software Developer
    • Margot van Fleeteren
      Manager Patient Engagement

    BOARD

    • Franco Taisch
      Board Chairman and Founding Partner
    • Otto Philipp Braun
      Crypto Entrepreneur and Investor
    • Tobias Diener
      Director Zolliger Foundation
    • Michael Dillhyon
      Founder and Healthtech Specialist
    • Jon Erni
      Director Miaengadina, Technology Specialist
    • Richard Frank
      Founding Partner and director Legal Alexion Pharma GmbH
    • Thomas Grechenig
      CEO of RISE, Prof. Informatics University Vienna
    • Christian Köpe
      Head Strategy and Affairs Galenica AG
    • Claus Moldenhauer
      Former Board Member DAK
    • Reto Stocker
      Chief Physician Hirslanden Clinic Zurich

    Advisory board and advisors

    • Andreas Amann
      Chariman Institute for Digital Innovation in HealthCare
    • Werner Christie
      Health Policy and life Science Expert
    • Felix Frueh
      Senior Executive in Personalized Medicine
    • Jane Sarasohn-Kahn
      Health Economist/Advisor
    • Jody Ranck
      VP Strategy and Business
    • Michael Stearns
      CEO Apollo Hit.
    • Guido Schüpfer
      Chief of Staff at Cantonal Hospital Lucerne
    • Melanie Swan
      Founder at Insitute for Blockchain Studies
    • Chris Leiter
      Digital Health Expert
    • Luke Szkudlarek
      Growth hacking Specialist

    Token Sale
    • Pre Sale Start
      September 17, 2018
    • Pre Sale End
      February 27, 2019
    • Main Sale Start
      February 28, 2019
    • Main Sale End
      May 31, 2019
    • Payment Methods
      ETH / CHF / EURO
    • Minimum Investment Goal
      none
    • Investment Goal
      CHF 27.6M
    • Bonus and Discount System
      1st round: 25%; 2nd round:15% for first two weeks, 10% for second two weeks, 5% for third two weeks
    • Public Sale Price
      1 HBE = CHF 0.0143
    Asset Details
    • Token Holder Rights
      Dividends, Profit Share, Equity Ownership, Redemption Right
    Token Holder Rights

    HBE is an equity token which represents a share of healthbank cooperative; dividend rights & long-term token value increase

    Token Details
    • Ticker
      HBE
    • Blockchain Platform
      Ethereum
    • Token Standard
      ERC20
    • Total Token Supply
      4'000'000'000
    • Available for Sale
      2'200'000'000
    Investor Requirements
    • Restricted Areas
      Citizens from Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People's Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldava, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia are not allowed
    Company Profile
    • Country of Origin
      Switzerland
    • Country of Incorporation
      Switzerland
    • Registered Office
      Blegistrasse 17a CH - 6340 Baar
    Regulation
    • Regulation
      US Securities and Exchange Commission - Reg A+, US Securities and Exchange Commission - Reg CF, US Securities and Exchange Commission - Reg D (506b, 506c), US Securities and Exchange Commission - Reg S, BaFin

    You May Also Be Interested In